Park West Asset Management’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-181,507	Closed	-$3.4M	–	60
2025 Q4	$3.4M	Sell	181,507 -1,102,574	-86%	-$18.3M	0.29%	45
2025 Q3	$18.7M	Sell	1,284,081 -515,000	-29%	-$6.51M	1.71%	28
2025 Q2	$19.8M	Sell	1,799,081 -5,163	-0.3%	-$50.2K	1.51%	31
2025 Q1	$16.1M	Buy	1,804,244 +11,256	+0.6%	+$105K	1.32%	31
2024 Q4	$16.9M	Sell	1,792,988 -70,000	-4%	-$637K	1.4%	31
2024 Q3	$15M	Buy	1,862,988 +162,988	+10%	+$1.41M	1.11%	32
2024 Q2	$14.4M	Buy	1,700,000 +542,837	+47%	+$4.9M	1.13%	35
2024 Q1	$10.4M	Buy	1,157,163 +257,163	+29%	+$2.38M	0.78%	29
2023 Q4	$10.1M	Sell	900,000 -1,083,251	-55%	-$10.9M	0.99%	28
2023 Q3	$17.1M	Buy	1,983,251 +262,500	+15%	+$2.53M	1.57%	18
2023 Q2	$17.8M	Sell	1,720,751 -179,452	-9%	-$1.98M	1.56%	18
2023 Q1	$20.6M	Sell	1,900,203 -20,121	-1%	-$213K	1.89%	16
2022 Q4	$21.5M	Buy	1,920,324 +970	+0.1%	+$10.2K	2.16%	15
2022 Q3	$19.5M	Sell	1,919,354 -1,253,900	-40%	-$11.7M	1.54%	19
2022 Q2	$28.8M	Buy	3,173,254 +2,833,254	+833%	+$26.1M	1.73%	19
2022 Q1	$3.25M	Buy	+340,000	New	+$3.33M	0.12%	64